Detection and localization of surgically resectable cancers with a multi-analyte blood test

Regularization and Variable Selection Via the Elastic Net

Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957 · see citing works

Regularization Paths for Generalized Linear Models via Coordinate Descent

Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927 · see citing works

Classification and Regression by randomForest

Liaw, A. I., & Wiener, M. C. (2007) · Cited by 18,594 · see citing works

Cancer Statistics, 2017.

Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712 · see citing works

Cancer Genome Landscapes

Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067 · see citing works

Age-related clonal hematopoiesis associated with adverse outcomes

Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · see citing works

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207 · see citing works

COSMIC: somatic cancer genetics at high-resolution

Forbes, S. A., Beare, D., Boutselakis, H., Bamford, S., Bindal, N., Tate, J., Cole, C. G., Ward, S., Dawson, E., Ponting, L., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1121 · Cited by 1,922 · see citing works

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Abbosh, C., Birkbak, N. J., Wilson, G. A., Jamal‐Hanjani, M., Constantin, T. P., Salari, R., Quesne, J. P. C. L., Moore, D. A., Veeriah, S., Rosenthal, R., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,880 · see citing works

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

Huang, A. C., Postow, M. A., Orlowski, R. J., Mick, R., Bengsch, B., Manne, S., Xu, W., Harmon, S., Giles, J. R., Wenz, B., et al. (2017) · Nature · doi:10.1038/nature22079 · Cited by 1,664 · see citing works

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Benson, A. B., Venook, A. P., Cederquist, L., Chan, E., Chen, Y., Cooper, H. S., Deming, D. A., Engstrom, P. F., Enzinger, P. C., Fichera, A., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0036 · Cited by 1,328 · see citing works

Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

Forshew, T., Murtaza, M., Parkinson, C., Gale, D. G., Tsui, D. W. Y., Kaper, F., Dawson, S., Piskorz, A., Jimenez‐Liñan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,298 · see citing works

Detection and quantification of rare mutations with massively parallel sequencing

Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,205 · see citing works

Detection and quantification of mutations in the plasma of patients with colorectal tumors

Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188 · see citing works

Direct detection of early-stage cancers using circulating tumor DNA

Phallen, J. A., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J. R., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,129 · see citing works

Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 924 · see citing works

Comparative lesion sequencing provides insights into tumor evolution

Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 817 · see citing works

Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA

Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 697 · see citing works

Evolutionary dynamics of cancer in response to targeted combination therapy

Božić, I., Reiter, J. G., Allen, B., Tibor Antal, A., Chatterjee, K., Shah, P., Moon, Y. S., Yaqubie, A., Kelly, N. E., Le, D. T., et al. (2013) · eLife · doi:10.7554/elife.00747 · Cited by 607 · see citing works

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

Cohen, J. D., Javed, A. A., Thoburn, C. J., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M., Allen, P. J., Schattner, M. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 581 · see citing works

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

Wang, Y., Springer, S. U., Jenks, C. M., Silliman, N., Schaefer, J., Sausen, M., James, N., Rettig, E. M., Guo, T. W., Pickering, C. R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8507 · Cited by 503 · see citing works

Liquid Biopsies, What We Do Not Know (Yet)

Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482 · see citing works

Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer

Makohon-Moore, A. P., Zhang, M., Reiter, J. G., Bozic, I., Allen, B., Kundu, D., Chatterjee, K., Wong, F., Jiao, Y., Kohutek, Z. A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3764 · Cited by 403 · see citing works

Intron retention is a widespread mechanism of tumor-suppressor inactivation

Jung, H., Lee, D., Lee, J., Park, D., Kim, Y. J., Park, W., Hong, D., Park, P. J., & Lee, E. (2015) · Nature Genetics · doi:10.1038/ng.3414 · Cited by 329 · see citing works

The Path to Cancer — Three Strikes and You're Out

Vogelstein, B., & Kinzler, K. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1508811 · Cited by 324 · see citing works

Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors

Yachida, S., White, C. M., Naito, Y., Zhong, Y., Brosnan, J. A., Macgregor-Das, A. M., Morgan, R. A., Saunders, T., Laheru, D. A., Herman, J. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1215 · Cited by 280 · see citing works

Panel of Serum Biomarkers for the Diagnosis of Lung Cancer

Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5392 · Cited by 249 · see citing works

Prostate Cancer Screening — A Perspective on the Current State of the Evidence

Pinsky, P. F., Prorok, P. C., & Kramer, B. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmsb1616281 · Cited by 124 · see citing works

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review

Cree, I. A., Uttley, L., Woods, H. B., Kikuchi, H., Reiman, A., Harnan, S., Whiteman, B. L., Taylor‐Phillips, S., Messenger, M. P., Cox, A., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3693-7 · Cited by 107 · see citing works

FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing

Kinde, I., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041162 · Cited by 70 · see citing works

The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification

Wang, H., Shi, T., Qian, W., Liu, T., Kagan, J., Srivastava, S., Smith, R. D., Rodland, K., & Camp, D. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1122529 · Cited by 62 · see citing works

Diagnostic potential of tumor DNA from ovarian cyst fluid

Wang, Y., Sundfeldt, K., Mateoiu, C., Shih, I., Kurman, R. J., Schaefer, J., Silliman, N., Kinde, I., Springer, S. U., Foote, M. B., et al. (2016) · eLife · doi:10.7554/elife.15175 · Cited by 40 · see citing works

The promise of proteomics

Liotta, L. A., & Petricoin, E. F. (1999) · Nature · doi:10.1038/45308 · Cited by 23 · see citing works

Predicting treatment resistance and relapse through circulating DNA

Beddowes, E. J., Sammut, S., Gao, M., & Caldas, C. (2017) · The Breast · doi:10.1016/j.breast.2017.06.024 · Cited by 21 · see citing works

Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings

Semrad, T. J., Fahrni, A. M. R., Gong, I.-Y., & Khatri, V. P. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4610-4 · Cited by 12 · see citing works

A view on drug resistance in cancer

Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770 · see citing works

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., Falco, V. D., Upadhyay, A., Kandimalla, R. J. L., Chaudhary, A., et al. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,936 · see citing works

Artificial intelligence in cancer imaging: Clinical challenges and applications

Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846 · see citing works

Current and future perspectives of liquid biopsies in genomics-driven oncology

Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557 · see citing works

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495 · see citing works

Genome-wide cell-free DNA fragmentation in patients with cancer

Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476 · see citing works

Early Detection of Cancer

Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379 · see citing works

Current state of immunotherapy for glioblastoma

Lim, M. K., Xia, Y., Bettegowda, C., & Weller, M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0003-5 · Cited by 1,373 · see citing works

Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258 · see citing works

The emerging roles of circRNAs in cancer and oncology

Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00585-y · Cited by 1,256 · see citing works

Liquid biopsy enters the clinic — implementation issues and future challenges

Ignatiadis, M., Sledge, G. W., & Jeffrey, S. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00457-x · Cited by 1,191 · see citing works

Liquid biopsy and minimal residual disease - latest advances and implications for cure

Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110 · see citing works

Enhanced detection of circulating tumor DNA by fragment size analysis

Mouliere, F. C., Chandrananda, D., Piskorz, A., Moore, E. K., Morris, J., Ahlborn, L. B., Mair, R. J., Goranova, T., Marass, F., Heider, K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4921 · Cited by 1,071 · see citing works

Targeting metastatic cancer

Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,070 · see citing works

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

Reinert, T., Henriksen, T. V., Christensen, E., Sharma, S., Salari, R., Sethi, H., Knudsen, M., Nordentoft, I., Wu, H.-T., Tin, A. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0528 · Cited by 1,011 · see citing works

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set

Klein, E. A., Richards, D., Cohn, A. L., Tummala, M., Lapham, R. L., Cosgrove, D. O., Chung, G. G., Clement, J., Gao, J., Hunkapiller, N. M., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.05.806 · Cited by 1,014 · see citing works

Sensitive tumour detection and classification using plasma cell-free DNA methylomes

Shen, S. Y., Singhania, R., Fehringer, G., Chakravarthy, A., Roehrl, M. H. A., Chadwick, D., Zuzarte, P. C., Borgida, A., Wang, T. T., Li, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0703-0 · Cited by 983 · see citing works

Liquid Biopsy: From Discovery to Clinical Application

Alix‐Panabières, C., & Pantel, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1311 · Cited by 983 · see citing works

Application of Cell-free DNA Analysis to Cancer Treatment

Corcoran, R. B., & Chabner, B. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706174 · Cited by 965 · see citing works

Liquid biopsy: current technology and clinical applications

Nikanjam, M., Kato, S., & Kurzrock, R. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01351-y · Cited by 963 · see citing works

Exosome-based liquid biopsies in cancer: opportunities and challenges

Wang, Y., Hurley, J. D., Roberts, D., Chakrabortty, S. K., Enderle, D., Noerholm, M., Breakefield, X. O., & Skog, J. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.01.074 · Cited by 871 · see citing works

Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.056 · Cited by 875 · see citing works

Early Detection of Pancreatic Cancer: Opportunities and Challenges

Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841 · see citing works

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: A report from the ESMO Precision Medicine Working Group

Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.520 · Cited by 783 · see citing works

Artificial Intelligence in Cancer Research and Precision Medicine

Bhinder, B., Gilvary, C., Madhukar, N. S., & Elemento, O. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0090 · Cited by 781 · see citing works

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

Razavi, P., Li, B. T., Brown, D. N., Jung, B., Hubbell, E. A., Shen, R., Abida, W. M., Juluru, K., de Bruijn, I., Hou, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0652-7 · Cited by 795 · see citing works

Strategies for Colorectal Cancer Screening

Ladabaum, U., Dominitz, J. A., Kahi, C., & Schoen, R. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.043 · Cited by 696 · see citing works

Integrating genomic features for non-invasive early lung cancer detection

Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., Schroers‐Martin, J. G., Nabet, B. Y., Chen, B., Chaudhuri, A. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2140-0 · Cited by 686 · see citing works

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

Rolfo, C., Mack, P., Scagliotti, G. V., Aggarwal, C., Arcila, M. E., Barlesi, F., Bivona, T., Diehn, M., Dive, C., Dziadziuszko, R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.06.017 · Cited by 683 · see citing works

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659 · see citing works

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

Lennon, A. M., Buchanan, A. H., Kinde, I., Warren, A., Honushefsky, A. M., Cohain, A. T., Ledbetter, D. H., Sanfilippo, F. P., Sheridan, K. M., Rosica, D., et al. (2020) · Science · doi:10.1126/science.abb9601 · Cited by 665 · see citing works

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

Jonasch, E. W., Walker, C. L., & Rathmell, W. K. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00359-2 · Cited by 647 · see citing works

Non-invasive early detection of cancer four years before conventional diagnosis using a blood test

Chen, X., Gole, J., Gore, A., He, Q., Lü, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17316-z · Cited by 637 · see citing works

Life and death of circulating cell-free DNA

Kustanovich, A., Schwartz, R., Peretz, T., & Grinshpun, A. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1598759 · Cited by 612 · see citing works

Circulating tumor DNA and liquid biopsy in oncology

Cescon, D. W., Bratman, S. V., Chan, S. M., & Siu, L. L. (2020) · Nature Cancer · doi:10.1038/s43018-020-0043-5 · Cited by 600 · see citing works

From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment.

Swanson, K., Wu, E., Zhang, A., Alizadeh, A. A., & Zou, J. (2023) · Cell · doi:10.1016/j.cell.2023.01.035 · Cited by 597 · see citing works

The emerging role of cell-free DNA as a molecular marker for cancer management

Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2019.100087 · Cited by 566 · see citing works

Next-generation sequencing in liquid biopsy: cancer screening and early detection

Chen, M., & Zhao, H. (2019) · Human Genomics · doi:10.1186/s40246-019-0220-8 · Cited by 561 · see citing works

Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells

Keller, L., & Pantel, K. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0180-2 · Cited by 549 · see citing works

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Seijo, L. M., Peled, N., Ajona, D., Boeri, M., Field, J. K., Sozzi, G., Pı́o, R., Zulueta, J. J., Spira, A. E., Massion, P. P., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.11.023 · Cited by 542 · see citing works

Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis

Rubis, G. D., Krishnan, S. R., & Bebawy, M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.006 · Cited by 533 · see citing works

Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention

Stoffel, E. M., Brand, R. E., & Goggins, M. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.012 · Cited by 540 · see citing works

Current and future colorectal cancer screening strategies

Shaukat, A., & Levin, T. R. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00612-y · Cited by 516 · see citing works

Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes

Shin, H., Oh, S., Hong, S., Kang, M.-S., Kang, D., Ji, Y.-G., Choi, B. H., Kang, K., Jeong, H., Park, Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b09119 · Cited by 508 · see citing works

Artificial Intelligence and Personalized Medicine

Schork, N. J. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-16391-4_11 · Cited by 518 · see citing works

Advances in the Early Diagnosis of Hepatocellular Carcinoma

Wang, W., & Wei, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.014 · Cited by 492 · see citing works

Quantitative evidence for early metastatic seeding in colorectal cancer

Hu, Z., Ding, J., Ma, Z., Sun, R., Seoane, J. A., Shaffer, J. S., Suarez, C. J., Berghoff, A. S., Cremolini, C., Falcone, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0423-x · Cited by 480 · see citing works

Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers

Liu, C., Zhao, J.-X., Tian, F., Cai, L., Zhang, W., Feng, Q., Chang, J.-Q., Wan, F., Yang, Y.-J., Dai, B., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0343-6 · Cited by 408 · see citing works

Early detection of pancreatic cancer

Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482 · see citing works

Molecular Biomarkers in Cancer

Sarhadi, V. K., & Armengol, G. (2022) · Biomolecules · doi:10.3390/biom12081021 · Cited by 498 · see citing works

DNA Methylation Cancer Biomarkers: Translation to the Clinic

Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K., Fung, K. Y. C., & Ross, J. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01150 · Cited by 472 · see citing works

Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., You, L., Zhang, T., Dai, M., & Zhao, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.027 · Cited by 475 · see citing works

The future of early cancer detection

Fitzgerald, R. C., Antoniou, A. C., Fruk, L., & Rosenfeld, N. (2022) · Nature Medicine · doi:10.1038/s41591-022-01746-x · Cited by 475 · see citing works

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.009 · Cited by 474 · see citing works

Colorectal cancer

Eng, C., Yoshino, T., Ruíz‐García, E., Mostafa, N., Cann, C., O’Brian, B., Benny, A., Perez, R. O., & Cremolini, C. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00360-x · Cited by 480 · see citing works

Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection

Abbosh, C., Birkbak, N. J., & Swanton, C. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0058-3 · Cited by 451 · see citing works

Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Pashayan, N., Antoniou, A. C., Ivanuš, U., Esserman, L. J., Easton, D. F., French, D., Sroczynski, G., Hall, P. N., Cuzick, J. M., Evans, D. G., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0388-9 · Cited by 443 · see citing works

Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy

Marrugo-Ramírez, J., Mir, M., & Samitier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102877 · Cited by 388 · see citing works

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer

Luo, H., Zhao, Q., Wei, W., Zheng, L., Yi, S., Li, G. L., Wang, W., Sheng, H., Pu, H., Mo, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7533 · Cited by 440 · see citing works

Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring

Zviran, A., Schulman, R. C., Shah, M., Hill, S. T., Deochand, S., Khamnei, C., Maloney, D., Patel, K., Liao, W., Widman, A. J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0915-3 · Cited by 375 · see citing works

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond

Keller, L., Belloum, Y., Wikman, H., & Pantel, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01047-5 · Cited by 402 · see citing works

Model to determine risk of pancreatic cancer in patients with new-onset diabetes

Sharma, A., Kandlakunta, H., Nagpal, S. J. S., Feng, Z., Hoos, W., Petersen, G. M., & Chari, S. T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.023 · Cited by 394 · see citing works

Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis

Menyhárt, O., & Győrffy, B. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.009 · Cited by 388 · see citing works

Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma

Vagner, T., Spinelli, C., Minciacchi, V. R., Balaj, L., Zandian, M., Conley, A., Zijlstra, A., Freeman, M. R., Demichelis, F., De, S., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1505403 · Cited by 375 · see citing works

Liquid biopsies: the future of cancer early detection

Connal, S., Cameron, J. M., Sala, A., Brennan, P. M., Palmer, D. S., Palmer, J. D., Perlow, H. K., & Baker, M. J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03960-8 · Cited by 387 · see citing works

Circulating tumour cells for early detection of clinically relevant cancer

Lawrence, R. L., Watters, M., Davies, C. R., Pantel, K., & Lu, Y. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00781-y · Cited by 378 · see citing works

Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

Bernard, V., Kim, D. U., Lucas, F. A. S., Castillo, J., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J. H., Semaan, A., Guerrero, P. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.022 · Cited by 364 · see citing works

Tracking cancer progression: from circulating tumor cells to metastasis

Castro-Giner, F., & Aceto, N. (2020) · Genome Medicine · doi:10.1186/s13073-020-00728-3 · Cited by 367 · see citing works

Large-scale pancreatic cancer detection via non-contrast CT and deep learning

Cao, K., Xia, Y., Yao, J., Han, X., Lambert, L., Zhang, T., Tang, W., Jin, G., Jiang, H., Fang, X., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02640-w · Cited by 358 · see citing works

Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade

Zhang, Q., Luo, J., Wu, S., Si, H., Gao, C., Xu, W., Abdullah, S. E., Higgs, B. W., Dennis, P. A., van der Heijden, M. S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0047 · Cited by 348 · see citing works

The Role of Artificial Intelligence in Early Cancer Diagnosis

Hunter, B., Hindocha, S., & Lee, R. W. (2022) · Cancers · doi:10.3390/cancers14061524 · Cited by 367 · see citing works

Liquid Biopsy: General Concepts

Poulet, G., Massias, J., & Taly, V. (2019) · Acta Cytologica · doi:10.1159/000499337 · Cited by 334 · see citing works

Liquid biopsy in breast cancer: A comprehensive review

Mirzaie, S., Bagherzadeh, M., & Akbari, M. R. (2019) · Clinical Genetics · doi:10.1111/cge.13514 · Cited by 336 · see citing works

Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA

van der Pol, Y., & Mouliere, F. C. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.09.003 · Cited by 324 · see citing works

Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics

Song, P., Wu, L. R., Yan, Y. H., Zhang, J. X., Chu, T., Kwong, L. N., Patel, A. A., & Zhang, D. Y. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00837-3 · Cited by 329 · see citing works

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

Johnson, P. J., Zhou, Q. X., Dao, D. Y., & Lo, Y. M. D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00620-y · Cited by 322 · see citing works

Evaluation of cell-free DNA approaches for multi-cancer early detection

Jamshidi, A., Liu, M., Klein, E. A., Venn, O., Hubbell, E. A., Beausang, J. F., Gross, S. S., Melton, C. A., Fields, A. P., Liu, Q., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.10.022 · Cited by 323 · see citing works

Circulating tumour DNA — looking beyond the blood

Tivey, A., Church, M., Rothwell, D., Dive, C., & Cook, N. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00660-y · Cited by 321 · see citing works

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

McDonald, B. R., Contente‐Cuomo, T., Sammut, S., Odenheimer-Bergman, A., Ernst, B. J., Perdigones, N., Chin, S., Farooq, M., Mejia, R., Cronin, P. A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7392 · Cited by 306 · see citing works

Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives

Xu, J., Yang, P., Xue, S., Sharma, B., Sanchez-Martin, M., Wang, F., Beaty, K. A., Dehan, E., & Parikh, B. (2019) · Human Genetics · doi:10.1007/s00439-019-01970-5 · Cited by 305 · see citing works

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients

Zhang, Y., Yao, Y., Xu, Y., Li, L., Gong, Y., Zhang, K., Zhang, M., Guan, Y., Chang, L., Xia, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20162-8 · Cited by 306 · see citing works

Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges

Yang, S., Lv, S., Zhang, W., & Cui, Y. (2022) · Sensors · doi:10.3390/s22041620 · Cited by 313 · see citing works

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes

Nuzzo, P. V., Berchuck, J. E., Korthauer, K. D., Spisák, S., Nassar, A. H., Alaiwi, S. A., Chakravarthy, A., Shen, S. Y., Bakouny, Z., Boccardo, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0933-1 · Cited by 299 · see citing works

Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring

Best, M. G., Wesseling, P., & Wurdinger, T. D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0887 · Cited by 298 · see citing works

Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer

Tian, F., Zhang, S., Liu, C., Han, Z., Liu, Y., Deng, J., Li, Y., Wu, X., Cai, L., Qin, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22913-7 · Cited by 287 · see citing works

Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine

Chen, Z., Lin, L., Wu, C., Li, C., Xu, R., & Sun, Y. H. (2021) · 癌症：英文版 · doi:10.1002/cac2.12215 · Cited by 291 · see citing works

Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living

Heitzer, E., Auinger, L., & Speicher, M. R. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.012 · Cited by 281 · see citing works

Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma

Chen, F., Dai, X., Zhou, C., Li, K.-X., Zhang, Y., Lou, X., Zhu, Y., Sun, Y., Peng, B.-X., & Cui, W. (2021) · Gut · doi:10.1136/gutjnl-2020-323476 · Cited by 286 · see citing works

Ovarian Cancer Prevention and Screening

Menon, U., Karpinskyj, C., & Gentry‐Maharaj, A. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002580 · Cited by 281 · see citing works

Liquid biopsies: Potential and challenges

Heidrich, I., Ačkar, L., Mohammadi, P. M., & Pantel, K. (2020) · International Journal of Cancer · doi:10.1002/ijc.33217 · Cited by 284 · see citing works

Classification and interaction in random forests

Denisko, D., & Hoffman, M. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800256115 · Cited by 279 · see citing works

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology

Deveson, I. W., Gong, B., Lai, K., LoCoco, J. S., Richmond, T., Schageman, J. J., Zhang, Z., Novoradovskaya, N., Willey, J. C., Jones, W. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00857-z · Cited by 280 · see citing works

Circulating biomarkers for early detection and clinical management of colorectal cancer

Marcuello, M., Vymetalkova, V. P., Neves, R. P., Durán-Sanchón, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., García‐Barberán, V., Fijneman, R. J. A., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 279 · see citing works

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection

Fiala, C., & Diamandis, E. P. (2018) · BMC Medicine · doi:10.1186/s12916-018-1157-9 · Cited by 274 · see citing works

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection

Ulz, P., Perakis, S. O., Zhou, Q. X., Moser, T., Belic, J., Lazzeri, I., Wölfler, A., Zebisch, A., Gerger, A., Pristauz, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12714-4 · Cited by 265 · see citing works

Convolutional neural network models for cancer type prediction based on gene expression

Mostavi, M., Chiu, Y., Huang, Y., & Chen, Y. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0677-2 · Cited by 266 · see citing works

Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology

Bartolomucci, A., de Nóbrega, M., Ferrier, S. T., Dickinson, K., Kaorey, N., Nadeau, A., Castillo, A., & Burnier, J. V. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00876-y · Cited by 287 · see citing works

Genomic Medicine–Progress, Pitfalls, and Promise

Shendure, J., Findlay, G. M., & Snyder, M. W. (2019) · Cell · doi:10.1016/j.cell.2019.02.003 · Cited by 253 · see citing works

Cancer evolution: Darwin and beyond

Vendramin, R., Litchfield, K., & Swanton, C. (2021) · The EMBO Journal · doi:10.15252/embj.2021108389 · Cited by 253 · see citing works

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of originPreprint

Sun, K., Jiang, P., Cheng, S. H., Cheng, T. H. T., Wong, J., Wong, V. W., Ng, S. S. M., Ma, B. B. Y., Leung, T. Y., Chan, S. L., et al. (2019) · Genome Research · doi:10.1101/gr.242719.118 · Cited by 254 · see citing works

Seeking Early Hints of Cancer in Blood: Combine to Conquer

Giraldez, M. D., & Tewari, M. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.041

CancerSEEK and destroy — a blood test for early cancer detection

Killock, D. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.21 · Cited by 48 · see citing works

Researchers Seek to Improve Early Cancer Detection With Gene-Based Tests

Nalley, C. (2018) · Oncology Times · doi:10.1097/01.cot.0000532459.17691.d1 · Cited by 1 · see citing works

NewsCAP: On the horizon: a blood test for identifying solid organ tumors and their origin

(2018) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000532060.86726.ef

Multiyear Clinical Outcomes of Cancers Diagnosed Following Detection by a Blood-Based Multicancer Early Detection Test

Buchanan, A. H., Lennon, A. M., Choudhry, O. A., Elias, P. Z., Rego, S. P., Sadler, J. R., Roberta, J., Zhang, Y., Flake, D. D., Salvati, Z. M., et al. (2024) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-24-0107 · Cited by 23 · see citing works